How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children

Specific immunotherapy (SIT) is used to treat asthma and allergic rhinitis, and a dose–response relationship has been found for SIT efficacy, creating a need to accurately select the allergen used in therapy. This need is especially pronounced in poly-sensitized children living in areas where different pollen allergen sources coexist in the same season, as this circumstance complicates diagnostic efforts. In such cases, component-resolved...